About Us

Chief Commercial Officer

Products Blogs
Anfeng Guo

Anfeng Guo

Mr. Anfeng Guo, was appointed as our chief commercial officer in September 1, 2022. He is primarily responsible for the overall strategic planning of the Group’s commercial markets. Mr. Anfeng Guo has over 20 years of experience in the pharmaceutical industry. From October 2017 to April 2000, Mr. Anfeng Guo was the head of sales of the Immuno-Oncology Lung Cancer Indications Business Unit at Bristol Myers Squibb, a company listed on the New York Stock Exchange (stock code: BMY). He served as the chief commercial officer at LinkDoc Technology (Beijing) Co., Ltd. from February 2021 to September 2022. Mr. Anfeng Guo received his bachelor’s degree in biological pharmacy from Nanjing University of Technologyin the PRC in June 2000. He obtained his Master of Business Administration degree from Nanjing Universityin the PRC in November 2018.